Construction Partners (NASDAQ: ROAD) acquires…
…
TRENDING
1.64 USD
6.01 USD
0.027 USD
1.29 USD
0.422 USD
0.0445 USD
6.36 USD
0.2254 USD
0.7375 USD
0.1334 USD
0.2999 USD
5.34 USD
0.8831 USD
4.55 USD
0.05 USD
11.93 USD
23.87 USD
0.0472 USD
0.0281 USD
0.2998 USD
If first you don’t succeed, re-submit to the FDA, FDA accepts (NASDAQ: REPL) BLA resubmission for melanoma drug Relumine Group Inc (NASDAQ: REPL) stock soared 60% after the U.S. Food and Drug Administration (FDA) accepted the company’s resubmission of a Biologics License Application (BLA) for its RP1 treatment. The BLA seeks approval for RP1 in combination with nivolumab to treat …